drugset / Trial / NCT02462187
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects with External Genital Warts and Perianal Warts
Timeline
- Start
- 2015-06-12
- Primary completion
- 2016-10
- Completion
- 2016-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BERDAZIMER SODIUM | Small molecule | 8 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 16 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 24 % | Topical |